Oruka Therapeutics Inc. (ORKA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Oruka Therapeutics Inc.

    NASDAQ: ORKA · Real-Time Price · USD
    19.79
    0.61 (3.18%)
    At close: Oct 03, 2025, 3:59 PM
    19.40
    -1.97%
    After-hours: Oct 03, 2025, 05:53 PM EDT

    Oruka Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -83.72M -9.93M -19.32M
    Depreciation & Amortization
    		 27K 114K 91K
    Stock-Based Compensation
    		 n/a n/a n/a
    Other Working Capital
    		 8.13M -878K 383K
    Other Non-Cash Items
    		 14.27M 561K 497K
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 11.59M -1.66M -28K
    Operating Cash Flow
    		 -57.84M -10.91M -18.76M
    Capital Expenditures
    		 -189K -2K -43K
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 -329.94M n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 -330.13M -2K -43K
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a
    Financial Cash Flow
    		 449.54M n/a 23.09M
    Net Cash Flow
    		 24.14M -10.91M 4.29M
    Free Cash Flow
    		 -58.03M -10.91M -18.8M

    Add to Watchlist